Articles
Every article, newest first. Plain answers, with the sources at the bottom.
GuideReconstitution guideHow to mix your peptides, and should you shake them?The free reconstitution guide: which water, how to add it, how to mix, how long it keeps, and where the never-shake rule really comes from.
George Massimo Totti4 Nov 20265 min readGuideSupplement guideShould you snort your creatine? The rat study and the 21 hour human testRats that got creatine up the nose had more of it in the brain and did better in a maze. A human study got a brain effect from one big swallowed dose. What both really showed.George Massimo Totti4 Nov 20265 min readPeptide233 papers~84 people studiedWhy can't you just swallow BPC-157? What your stomach does to peptidesYour stomach breaks down protein, so most peptides are shots. Even the Ozempic pill gets about 1% in. BPC-157 came from stomach juice, and in rats it worked in drinking water. What that does and doesn't prove.George Massimo Totti4 Nov 20264 min readGuidePeptide guideShould you snort your peptides? The ones that are made for the noseSemax is a Russian medicine sold as nose drops. What the BDNF study really showed, which other peptides are approved as nasal sprays, and why most peptides are not.George Massimo Totti4 Nov 20266 min readGuideInjection guideHow to pin the right way: where, how and what goes wrongFat or muscle, belly, thigh or arm, how to move the spot, whether to pin into the injury, what happens if you hit a vein, and the Z-track for shots that leak.George Massimo Totti4 Nov 202615 min readPeptide233 papers~84 people studiedDo BPC-157 and TB-500 cause cancer?BPC-157 and thymosin beta-4, the protein behind TB-500, grow new blood vessels in animals. Tumors need blood vessels. What the studies show.George Massimo Totti4 Nov 20266 min readPeptide101 papers~350 people studiedGHK-Cu: $300 a month at the clinic vs a vialClinic GHK-Cu protocols run $100 to $300+ a month, but no published human study has tested injected GHK-Cu on its own.George Massimo Totti4 Nov 20265 min readPeptide233 papers~84 people studiedBPC-157: what the studies really showAbout 84 people have received BPC-157 in published research. None got it by the routes most users take.
Jan Polansky4 Nov 20267 min readPeptide198 papers~7,900 people studiedRetatrutide: what the trials show so farRetatrutide reached 25% weight loss on the top dose in one phase 3 trial but is not approved anywhere.George Massimo Totti4 Nov 20265 min readPeptide1,059 papers0 people studiedTB-500 vs BPC-157: two healing peptides comparedTB-500 has no human study of its own and BPC-157 has reached about 84 people, with no completed injury trial for either.Jan Polansky4 Nov 20267 min readPeptide101 papers~350 people studiedGHK-Cu for skin and hair: what holds upWhat the published human studies of GHK-Cu actually show for skin and hair, and where the evidence stops.George Massimo Totti4 Nov 20265 min readPeptide5,810 papers~160,000 people studiedSemaglutide: what the trials showRoughly 160,000 people have enrolled in semaglutide trials on weight loss, heart risk, side effects and what happens after stopping.George Massimo Totti4 Nov 20265 min readPeptide54 papers~320 people studiedIpamorelin: what we know and what we don'tIpamorelin triggers a growth hormone pulse in one IV study, but no one has published data on the subcutaneous use people actually do.Jan Polansky4 Nov 20265 min read
George Massimo Totti4 Nov 20265 min readGuideSupplement guideShould you snort your creatine? The rat study and the 21 hour human testRats that got creatine up the nose had more of it in the brain and did better in a maze. A human study got a brain effect from one big swallowed dose. What both really showed.
George Massimo Totti4 Nov 20265 min readPeptide233 papers~84 people studiedWhy can't you just swallow BPC-157? What your stomach does to peptidesYour stomach breaks down protein, so most peptides are shots. Even the Ozempic pill gets about 1% in. BPC-157 came from stomach juice, and in rats it worked in drinking water. What that does and doesn't prove.
George Massimo Totti4 Nov 20264 min readGuidePeptide guideShould you snort your peptides? The ones that are made for the noseSemax is a Russian medicine sold as nose drops. What the BDNF study really showed, which other peptides are approved as nasal sprays, and why most peptides are not.
George Massimo Totti4 Nov 20266 min readGuideInjection guideHow to pin the right way: where, how and what goes wrongFat or muscle, belly, thigh or arm, how to move the spot, whether to pin into the injury, what happens if you hit a vein, and the Z-track for shots that leak.
George Massimo Totti4 Nov 202615 min readPeptide233 papers~84 people studiedDo BPC-157 and TB-500 cause cancer?BPC-157 and thymosin beta-4, the protein behind TB-500, grow new blood vessels in animals. Tumors need blood vessels. What the studies show.George Massimo Totti4 Nov 20266 min readPeptide101 papers~350 people studiedGHK-Cu: $300 a month at the clinic vs a vialClinic GHK-Cu protocols run $100 to $300+ a month, but no published human study has tested injected GHK-Cu on its own.
George Massimo Totti4 Nov 20265 min readPeptide233 papers~84 people studiedBPC-157: what the studies really showAbout 84 people have received BPC-157 in published research. None got it by the routes most users take.Jan Polansky4 Nov 20267 min readPeptide198 papers~7,900 people studiedRetatrutide: what the trials show so farRetatrutide reached 25% weight loss on the top dose in one phase 3 trial but is not approved anywhere.
George Massimo Totti4 Nov 20265 min readPeptide1,059 papers0 people studiedTB-500 vs BPC-157: two healing peptides comparedTB-500 has no human study of its own and BPC-157 has reached about 84 people, with no completed injury trial for either.
Jan Polansky4 Nov 20267 min readPeptide101 papers~350 people studiedGHK-Cu for skin and hair: what holds upWhat the published human studies of GHK-Cu actually show for skin and hair, and where the evidence stops.George Massimo Totti4 Nov 20265 min readPeptide5,810 papers~160,000 people studiedSemaglutide: what the trials showRoughly 160,000 people have enrolled in semaglutide trials on weight loss, heart risk, side effects and what happens after stopping.
George Massimo Totti4 Nov 20265 min readPeptide54 papers~320 people studiedIpamorelin: what we know and what we don'tIpamorelin triggers a growth hormone pulse in one IV study, but no one has published data on the subcutaneous use people actually do.
Jan Polansky4 Nov 20265 min readWant a protocol built for you?Protocols, the full Vault and live calls with Jan, inside the Room.
Join the Room